Higher susceptibility of NOG mice to xenotransplanted tumors

Journal of Toxicological Sciences

Volumn 34, Issue 1, 2009, Pages 123-127

  Machida, Kazuhiko ^a   Suemizu, Hiroshi ^a   Kawai, Kenji ^a   Ishikawa, Tsuyoshi ^b   Sawada, Rumi ^b   Ohnishi, Yasuyuki ^a   Tsuchiya, Toshie ^b  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Hela s3; Nod shi scid il2rgnull (nog); Tumorigenicity testing; Xenograft

Indexed keywords

HLA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE STRAIN; NOG MOUSE; NONHUMAN; NUDE MOUSE; SCID MOUSE; TUMOR GROWTH; XENOTRANSPLANTATION;

MUS; MUS MUSCULUS;

EID: 59949091577     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.123     Document Type: Article

References (21)

1. Badayan, I. and Cudkowicz, M.E. (2008): Is it too soon for mesenchymal stem cell trials in people with ALS? Amyotroph. Lateral Scler., Sept. 9, 321-322.
2. Balducci, M., Santoro, R., Mancini, G. and Balducci, D. (1962): Analysis of different cell systems for the production of attenuated poliomyelitis virus vaccine. Appl. Microbiol., 10, 190-192.
3. Dalbello-Haas, V., Florence, J.M. and Krivickas, L.S. (2008): Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst. Rev., CD005229.
4. Delzer, J., Hauser, H. and Lehmann, J. (1985): Production of human interferon-beta in mouse L-cells. Dev. Biol. Stand., 60, 413-419.
5. Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., Heike, T. and Nakahata, T. (2002): NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood, 100, 3175-3182.
6. Ito, M., Kobayashi, K. and Nakahata, T. (2008): NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr. Top. Microbiol. Immunol., 324, 53-76.
7. Koyanagi, Y., Tanaka, Y., Kira, J., Ito, M., Hioki, K., Misawa, N., Kawano, Y., Yamasaki, K., Tanaka, R., Suzuki, Y., Ueyama, Y., Terada, E., Tanaka, T., Miyasaka, M., Kobayashi, T., Kumazawa, Y. and Yamamoto, N. (1997): Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J. Virol., 71, 2417-2424.
8. Masters, J.R. (2002): HeLa cells 50 years on: the good, the bad and the ugly. Nat. Rev. Cancer, 2, 315-319.
9. Masuda, H., Maruyama, T., Hiratsu, E., Yamane, J., Iwanami, A., Nagashima, T., Ono, M., Miyoshi, H., Okano, H.J., Ito, M., Tamaoki, N., Nomura, T., Okano, H., Matsuzaki, Y. and Yoshimura, Y. (2007): Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice. PNAS, 104, 1925-1930.
10. Matsuura-Sawada, R., Murakami, T., Ozawa, Y., Nabeshima, H., Akahira, J., Sato, Y., Koyanagi, Y., Ito, M., Terada, Y. and Okamura, K. (2005): Reproduction of menstrual changes in transplanted human endometrial tissue in immunodeficient mice. Hum. Reprod., 20, 1477-1484.
11. Moll, R., Franke, W.W., Schiller, D.L., Geiger, B. and Krepler, R. (1982): The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31, 11-24.
12. Nakamura, M. and Suemizu, H. (2008): Novel metastasis models of human cancer in NOG mice. Curr. Top. Microbiol. Immunol., 324, 167-177.
13. Ohbo, K., Suda, T., Hashiyama, M., Mantani, A., Ikebe, M., Miyakawa, K., Moriyama, M., Nakamura, M., Katsuki, M., Takahashi, K., Yamamura, K. and Sugamura, K. (1996): Modulation of hematopoiesis in mice with a truncated mutant of the inter-leukin-2 receptor gamma chain. Blood, 87, 956-967.
14. Okita, K., Ichisaka, T. and Yamanaka, S. (2007): Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313-317.
15. Robinson, D.M., Berman, S., Lowenthal, J.P. and Hetrick, F.M. (1966): Western equine encephalomyelitis vaccine produced in chick embryo cell cultures. Appl. Microbiol., 14, 1011-1014.
16. Sambrook, J., Hanahan, D., Rodgers, L. and Gething, M.J. (1986): Expression of human tissue-type plasminogen activator from lytic viral vectors and in established cell lines. Mol. Biol. Med., 3, 459-481.
17. Suemizu, H., Monnai, M., Ohnishi, Y., Ito, M., Tamaoki, N. and Nakamura, M. (2007): Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammac-null (NOG) mice. Int. J. Oncol., 31, 741-751.
18. Suemizu, H., Hasegawa, M., Kawai, K., Taniguchi, K., Monnai, M., Wakui, M., Suematsu, M., Ito, M., Peltz, G. and Nakamura, M. (2008): Establishment of a humanized model of liver using NOD/Shi-scid IL2Rg(null) mice. Biochem. Biophys. Res. Commun., 377, 248-252.
19. Taghian, A., Budach, W., Zietman, A., Freeman, J., Gioioso, D., Ruka, W. and Suit, H.D. (1993): Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Cancer Res., 53, 5012-5017.
20. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007): Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
21. + cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J. Immunol., 169, 204-209.